MediciNova, Inc.
IBUDILAST ORAL FORMULATIONS AND METHODS OF USING SAME
Last updated:
Abstract:
This disclosure is directed to ibudilast higher dosage oral formulations, such as tablet or capsule formulations, and the corresponding methods of treatment.
Status:
Application
Type:
Utility
Filling date:
21 Sep 2020
Issue date:
25 Mar 2021